Stem Cell Research

Published by: RI Technologies

Published: May. 1, 2008 - 349 Pages

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Foreword

Stem Cells

Segmentation of Stem Cells

Exhibit 1: Segmentation of Global Stem Cells Market by Stem Cell Type (Adult Stem Cells,

Embryonic Stem Cells and Cord Blood Stem Cells), Technology (SC Transplantation,

Cell Based Genomics, Xenotransplantation, Cord Blood Banking and Other) and

Therapeutic Area (Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology,

Diabetes and Other)

2. Global Market Analysis

Exhibit 2: Stem Cells (2005-2012) - Global Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Analysis by Stem Cell Type

Adult Stem Cells

Market Overview

Exhibit 3: Adult Stem Cells (2005-2012) - Global Market Analysis (Current & Future)

by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 4: Adult Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Cord Blood Stem Cells

Market Overview

Exhibit 5: Cord Blood Stem Cells (2005-2012) - Global Market Analysis (Current & Future)

by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 6: Cord Blood Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Embryonic Stem Cells

Market Overview

Exhibit 7: Embryonic Stem Cells (2005-2012) - Global Market Analysis (Current & Future)

by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 8: Embryonic Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Analysis by Technology

Stem Cell Transplantation

Market Overview

Exhibit 9: Stem Cell Transplantation (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)

Exhibit 10: Stem Cell Transplantation (2006, 2009 and 2012) - Percentage Breakdown

of Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Cell Based Genomics

Market Overview

Exhibit 11: Cell Based (CB) Genomics (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe, Asia-Pacific

and Rest of World in US$ Million (Graphical Representation included)

Exhibit 12: Cell Based (CB) Genomics (2006, 2009 and 2012) - Percentage Breakdown

of Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Xenotransplantation

Market Overview

Exhibit 13: Xenotransplantation (2005-2012) - Global Market Analysis (Current & Future)

by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 14: Xenotransplantation (2006, 2009 and 2012) - Percentage Breakdown of

Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Cord Blood Banking

Market Overview

Exhibit 15: Cord Blood Banking (2005-2012) - Global Market Analysis (Current & Future)

by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 16: Cord Blood Banking (2006, 2009 and 2012) - Percentage Breakdown of

Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Other

Exhibit 17: Other Stem Cell Technologies (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 18: Other Stem Cell Technologies (2006, 2009 and 2012) - Percentage Breakdown

of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific

and Rest of World (Graphical Representation included)

Analysis by Therapeutic Area

Neurology

Market Overview

Exhibit 19: Stem Cells in Neurology (2005-2012) - Global Market Analysis (Current &

Future) by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 20: Stem Cells in Neurology (2006, 2009 and 2012) - Percentage Breakdown of

Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Bone and Cartilage

Market Overview

Exhibit 21: Stem Cells in Bone and Cartilage Therapy (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 22: Stem Cells in Bone and Cartilage Therapy (2006, 2009 and 2012) - Percentage

Breakdown of Global Market Value by Geographic Region for North America,

Europe, Asia-Pacific and Rest of World (Graphical Representation included)

Cancer

Market Overview

Exhibit 23: Stem Cells in Cancer Therapy (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)

Exhibit 24: Stem Cells in Cancer Therapy (2006, 2009 and 2012) - Percentage Breakdown

of Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Hematology

Market Overview

Exhibit 25: Stem Cells in Hematology (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)

Exhibit 26: Stem Cells in Hematology (2006, 2009 and 2012) - Percentage Breakdown

of Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Cardiology

Market Overview

Exhibit 27: Stem Cells in Cardiology (2005-2012) - Global Market Analysis (Current &

Future) by Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 28: Stem Cells in Cardiology (2006, 2009 and 2012) - Percentage Breakdown

of Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Dermatology

Market Overview

Exhibit 29: Stem Cells in Dermatology (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe, Asia-Pacific

and Rest of World in US$ Million (Graphical Representation included)

Exhibit 30: Stem Cells in Dermatology (2006, 2009 and 2012) - Percentage

Breakdown of Global Market Value by Geographic Region for North America,

Europe, Asia-Pacific and Rest of World (Graphical Representation included)

Diabetes

Market Overview

Exhibit 31: Stem Cells in Diabetes Treatment (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe, Asia-Pacific

and Rest of World in US$ Million (Graphical Representation included)

Exhibit 32: Stem Cells in Diabetes Treatment (2006, 2009 and 2012) - Percentage

Breakdown of Global Market Value by Geographic Region for North America,

Europe, Asia-Pacific and Rest of World (Graphical Representation included)

Other

Exhibit 33: Stem Cells in Other Therapeutics (2005-2012) - Global Market Analysis

(Current & Future) by Geographic Region for North America, Europe, Asia-Pacific

and Rest of World in US$ Million (Graphical Representation included)

Exhibit 34: Stem Cells in Other Therapeutics (2006, 2009 and 2012) - Percentage

Breakdown of Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

Exhibit 35: List of Major Global Companies

3. Regional Market Analysis

North America

Exhibit 36: Stem Cells (2005-2012) - North American Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Europe

Exhibit 37: Stem Cells (2005-2012) - European Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Asia-Pacific

Exhibit 38: Stem Cells (2005-2012) - Asia-Pacific Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Rest of World

Exhibit 39: Stem Cells (2005-2012) - Rest of World Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

III. PRODUCT/TECHNOLOGY RESEARCH

1. Introduction

Stem Cells

Stem Cells Growth Trends - Global Markets

Exhibit 40: Global Market for Stem Cells: Geographic Regions (Asia-Pacific, Europe,

North America and Rest of World) Ranked by Projected CAGR for 2005

through 2012 (Graphical Representation included)

Cell Differentiation

Totipotent Stem Cells

Pluripotent Stem Cells

Multipotent Stem Cells

Unipotent Stem Cells

Importance of Stem Cells

Properties of Stem Cells

Stem Cell Research

Backdrop

Major Milestones in Stem Cell Research

Exhibit 41: The Evolution of Stem Cell Research

Categorization of Stem Cells

Global Market Growth Trends - Stem Cell Categories

Exhibit 42: Global Market for Stem Cells: Major Stem Cell Categories (CB Stem Cell,

Embryonic Stem Cell and Adult Stem Cell) Ranked by Projected CAGR

for 2005 through 2012 (Graphical Representation included)

Embryonic Stem Cells

Derivation of Embryonic Stem Cells

Differentiation of hESCs

Directed Differentiation

Directed Differentiation of hESCs in Chemically Defined Medium Conditions

Adult Stem Cells

Various Tests for Detection of Adult Stem Cells

Differentiation of Adult Stem Cells

Adult Stem Cell Plasticity and Transdifferntiation

Applications of Adult Stem Cells

Major Disease Areas of Adult Stem Cells

Cord Blood Stem Cells

Derivation of Stem Cells: Cord Blood Vs Bone Marrow

Stem Cells and Technologies

Growth Trends - Global Stem Cell Technologies

Exhibit 43: Global Market for Stem Cells: Major Stem Cell Technologies (Cord Blood Banking,

Xenotransplantation, SC Transplantation, Cell Based Genomics and Other) Ranked by

Projected CAGR for 2005 through 2012 (Graphical Representation included)

Stem Cell Transplantation

Need for Stem Cell Transplantation

The Process of Stem Cell Transplantation

Growth Trends - Global Market for Stem Cell Transplantation

Exhibit 44: Global Market for Stem Cell Transplantation: Geographic Regions (Asia-Pacific,

North America, Europe and Rest of World) Ranked by Projected CAGR for

2005 through 2012 (Graphical Representation included)

Cell Based Genomics

Growth Trends - Global Market for Cell Based Genomics

Exhibit 45: Global Market for Cell Based Genomics: Geographic Regions (Asia-Pacific, Europe,

North America and Rest of World) Ranked by Projected CAGR

for 2005 through 2012 (Graphical Representation included)

Xenotransplantation

Malfunctioning of Stem Cells Used for Xenotransplantation

Growth Trends - Global Market for Xenotransplantation

Exhibit 46: Global Market for Xenotransplantation: Geographic Regions (Asia-Pacific,

North America, Europe and Rest of World) Ranked by Projected CAGR

for 2005 through 2012 (Graphical Representation included)

Cord Blood Banking

Exhibit 47: Global Private Cord Blood Banks by

Geographic Region (2006) (Graphical Representation included)

Applications of Cord Blood

Growth Trends - Global Market for Cord Blood Banking

Exhibit 48: Global Market for Cord Blood Banking: Geographic Regions (Asia-Pacific,

Europe, North America and Rest of World) Ranked by Projected CAGR

for 2005 through 2012 (Graphical Representation included)

Other Technologies Related to Stem Cells

Stem Cell Research and Cloning

The Process of Cloning

Stem cell cultivation

How Stem Cell Research Differs from Cloning?

Stem Cell Therapy and Mammalian Cloning

The Challenges

Cloning Technologies

Therapeutic Cloning

Reproductive Cloning

Somatic Cell Nuclear Transfer

Limitations of SCNT

Concerns with Stem Cell Research

Ethical Issues in Stem Cell Research

2. Embryonic Stem Cell Research

Growth Trends - Global Market for Embryonic Stem Cells

Exhibit 49: Global Market for Embryonic Stem Cells: Geographic Regions (Asia-Pacific,

North America, Europe and Rest of World) Ranked by Projected CAGR

for 2005 through 2012 (Graphical Representation included)

Therapeutic Applications and Research Prospects

Multipotent Adult Progenitor Cells

Therapeutic Applications - The ESC Approach

Human ESCs Replication for Tissue Repair and Transplantation

Embryonic Stem Cells Application for Heart Disease

Human and Mouse Embryonic Stem Cell - The Proteomic Approach

Undifferentiated Human Embryonic Stem Cells for Formation of Blood Cells

Human Embryonic Stem Cell (hESC) Lines

Embryo Selection

The Process of hESCs Derivation

Blastocyst Embryo Transfer

Genetic Handling of hESCs

hESC Markers

Single-Cell Embryo Biopsy

Stem Cell Derivation through Embryo Biopsy

3. Adult Stem Cell Research

Growth Trends - Global Market for Adult Stem Cells

Exhibit 50: Global Market for Adult Stem Cells: Geographic Regions (Asia-Pacific, Europe,

North America and Rest of World) Ranked by Projected CAGR

for 2005 through 2012 (Graphical Representation included)

Types of HSCs

The Short-Term Precursor or Progenitor Cells

The Long-Term HSCs

Characteristics of HSCs

Sources of Hematopoietic Stem Cells

Bone Marrow

Peripheral Circulating Blood

Advantages of HSCs

Challenges in the Research of HSCs

Clinical Application of Hematopoietic Stem Cells

Leukemia and Lymphoma

Hereditary Blood Disorders

Hematopoietic Stem Cell Rescue in Treatment of Cancer

Treatment of Cancerous Tumors

Other Applications of HSCs

Plasticity of Hematopoietic Stem Cells

Challenges in Developing HSC Treatments

4. Cord Blood Stem Cells

Growth Trends - Global Market for Cord Blood Stem Cells

Exhibit 51: Global Market for Cord Blood Stem Cells: Geographic Regions (Asia-Pacific,

North America, Europe and Rest of World) Ranked by Projected

CAGR for 2005 through 2012 (Graphical Representation included)

Collection Process of Cord Blood

Cryo-Preservation of Cord Blood Stem Cells

Artificial Cryo-Preservation

Advantages of Cord Blood

Other Side of the Coin

5. Stem Cells in Therapeutics

Growth Trends - Global Stem Cell Therapeutic Areas

Exhibit 52: Global Market for Stem Cells: Major Therapeutic Areas (Neurology, Bone and

Cartilage, Dermatology, Diabetes, Hematology, Cardiology, Cancer and Other) Ranked by

Projected CAGR for 2005 through 2012 (Graphical Representation included)

Cancer

BMT and PBSCT: Cancer Treatment

BMT and PBSCT - Cancer Types

Extraction of Stem Cells

Extraction from Bone Marrow

Risk Factors for the Donor

Extraction from Peripheral Blood

Risk Factors for the Donor

Extraction from Umbilical Cord

Cancer Stem Cell Transplant Process

Mini-Transplant

Tandem Transplant

Post Transplant Functioning of Stem Cells

Expenses for BMT or PBSCT

Cancer Immunotherapy

Scientific Resources of Cancer Immunotherapy

NK-92 Cell Based Cancer Therapy

Genetically Modified NK-92 Cells for Cancer Therapy

Stem Cell Vaccines for Cancer Therapy - Developed by Gene Modification

Dendritic Cell Vaccines

Fundamentals of Dendritic Cell Vaccines

The B-Cell Vaccine variety

Hybrid Cell vaccination

General Side Effects with Stem Cell Transplantation

Consequences and Medication

Complications with PBSCT in Breast Cancer Patients

Growth Trends - Global Market for Stem Cells in Cancer Treatment

Exhibit 53: Global Market for Stem Cells in Cancer Treatment: Geographic Regions

(Asia-Pacific, North America, Europe and Rest of World) Ranked by

Projected CAGR for 2005 through 2012 (Graphical Representation included)

Cardiovascular Disorders

Cardiac Stem Cells

Myocyte Formation from Cardiac Stem Cells

Stem Cell Transplants for Congestive Heart Failure

Autologous Adult Stem Cell Transplantation

Myocardial Regeneration

Treatment for Ischemic Heart Failure with Cellular Cardiomyoplasty

The Relation between Left Ventricular Function and Release of Cardioactive Cytokines

Cell-Based Myocardial Repair

Autologous Skeletal Myoblasts

Cardiocytes and Stem Cells

Stem Cells Therapeutic Application for Cardiovascular Syndrome

Severe Coronary Artery Disease - Stem Cell Approach

Stem Cells Therapy for Hepatic Disorders

Growth Trends - Global Market for Stem Cells in Cardiovascular Disorders Treatment

Exhibit 54: Global Market for Stem Cells in Cardiovascular Disorders Treatment:

Geographic Regions (Asia-Pacific, Europe, North America and Rest of World)

Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)

Neurological Disorders - Stem Cell Therapy

Properties of Neural Stem Cells

Transformation of Neural Stem Cells into Other Cell Types

The Process of Transformation

Molecular Mechanisms

Stem Cells in Other Neoplasms

Cell Therapy for Neurodegenerative Disorders

Can Alzheimer’s be cured with Stem Cells?

Alternative Methods for Alzheimer’s Treatment

Stem Cell Therapy for Amyotrophic Lateral Sclerosis

Stroke Therapy using Human Adult Neural Stem Cells

Acute Ischemic Stroke

Cerebral Palsy Treatment - The Stem Cell Approach

Role of Chemokines

Techniques and Risks for Stem Cell Therapy

Stem Cell Therapy for Traumatic Brain Injury

Stem Cell Transplantation - A Novel Approach to Epilepsy Treatment

Growth Trends - Global Market for Stem Cells in Neurological Disorders Treatment

Exhibit 55: Global Market for Stem Cells in Neurological Disorders Treatment:

Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked

by Projected CAGR for 2005 through 2012 (Graphical Representation included)

Bone and Cartilage Regeneration

Application of Mesenchymal Stem Cells in Regeneration of Bone

Molecular and Tissue Engineering Strategies for the Use of Mesenchymal

Stem Cells in Bone Regeneration

Application of Adult Stem Cells in Cartilage Regeneration and Tissue Engineering

About Mesenchymal Stem Cells

Clinical Applications and Future of Cell Therapy

Growth Trends - Global Market for Stem Cells in Bone and Cartilage Disorders Treatment

Exhibit 56: Global Market for Stem Cells in Bone and Cartilage Disorders Treatment:

Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by

Projected CAGR for 2005 through 2012 (Graphical Representation included)

Hematological Disorders

Treatment for Blood Disorders

Stem Cell Treatment for Blood Disorder

Sickle Cell Anemia

Gene Therapy

Stem Cell Transplantation

Cord Blood Transplantation

Growth Trends - Global Market for Stem Cells in Hematology

Exhibit 57: Global Market for Stem Cells in Hematology: Geographic Regions (Asia-Pacific,

Europe, North America and Rest of World) Ranked by Projected CAGR

for 2005 through 2012 (Graphical Representation included)

Stem Cell Therapy for Diabetes Mellitus

Type 1 Diabetes in Children

Cord Blood Stem Cells for Treatment of Type 1 Diabetes

Growth Trends - Global Market for Stem Cells in Diabetes Treatment

Exhibit 58: Global Market for Stem Cells in Diabetes Treatment: Geographic Regions

(Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected

CAGR for 2005 through 2012 (Graphical Representation included)

Stem Cell Therapy in Dermatology

Cosmetic Applications

Intended Accomplishment by Stem Cells in Cosmetology

Growth Trends - Global Market for Stem Cells in Dermatology

Exhibit 59: Global Market for Stem Cells in Dermatology: Geographic Regions

(Asia-Pacific, North America, Europe and Rest of World) Ranked by Projected

CAGR for 2005 through 2012 (Graphical Representation included)

Stem Cells Research - A New Hope in Cosmetology

Breast Enhancement Treatment using Stem Cells

Effectiveness of Stem Cells in Rejuvenating Skin

Medicinal and Cosmetic Applications of Fat Derived Stem Cells

Bone and Muscles from Skin Stem Cells

Genetic Cosmetics - A Solution for Aging skin

Stem Cell Based Therapeutic Application for Treatment of Eyes and an

Unusual Skin Disorder

Stem Cell Aging Control by Extrinsic and Intrinsic Process

Adult Stem Cells - Creation of Soft Tissue

Other Major Therapeutic Areas of Stem Cells

Renal Applications

The Renal Papilla is Niche for Adult Kidney Cells

Stem Cell Applications in Transplantable Organs

Orthopedic Applications

Spinal Cord Regeneration

Review of Various Cell Therapies Used In the Field Of Orthopedics

Endocrine Applications of Stem Cells

Ophthalmic Applications of Stem cells

Prospects of Stem-Cell Based Treatment for Eye Disorders

Stem Cells Research in Neurology

Stem Cells Research in Dentistry

6. Technological Advances

Identification of a Versatile Stem Cell in the Amniotic Fluid

Why Caucasians are more in Number among Stem Cell Transplant Recipients?

The Creation of Tissue-Matched Stem Cells in Mice without the Cloning Process

Stem Cell Transplants -- Increased Risk for Diabetes and Hypertension

The Generation of Human Embryonic Stem Cell Lines from Dead Embryos

Self-Renewal of Embryonic Stem Cells Dependent upon the Small Molecule

7. Prospective Applications

IV. MARKET DYNAMICS

1. Market Overview

Global Market Analysis

Exhibit 60: Stem Cells (2005-2012) - Global Market Analysis (Current & Future) by

Geographic Region for North America, Europe, Asia-Pacific and

Rest of World in US$ Million (Graphical Representation included)

Exhibit 61: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Global Market Value by Geographic Region for North America, Europe,

Asia-Pacific and Rest of World (Graphical Representation included)

2. Stem Cell Trends

The Future of Cloned Food

Adult Stem Cells to Play Key Role in Heart Diseases

Use of Robotics in Stem Cell Research Automation

Identification of New Stem Cell with Dual Characteristics

Stem Cell Derivation from a Single Cell Extracted from Early Human Embryos

Reprogramming of Adult Stem Cells

Adult Stem Cells - Free of Controversy and Yield Better Results

Stem Cell Research Prospects in China

3. Major Companies in Stem Cell Market

Aastrom Biosciences, Inc. (USA)

Advanced Cell Technology, Inc. (USA)

Aldagen, Inc. (USA)

Angel BioTechnology Holdings PLC (UK)

Axordia Ltd. (UK)

BioE Corporation (USA)

BrainStorm Cell Therapeutics, Inc. (USA)

Cellartis AB (Sweden)

Cellerant Therapeutics, Inc. (USA)

Cellerix SA (Spain)

Cells4Life Ltd. (UK)

Cellular Dynamics International (USA)

CordLife Ltd. (Australia)

Cryo-Cell International, Inc. (USA)

CryoGENESIS International Ltd (UK)

Cryo-Save AG (The Netherlands)

Cytori Therapeutics, Inc. (USA)

Epistem PLC (UK)

ES Cell International Pte Ltd. (Singapore)

Gamida Cell Ltd. (Israel)

GE Healthcare (UK)

Geron Corporation (USA)

Invitrogen Corp. (USA)

Lazaron Biotechnologies (SA) Ltd. (South Africa)

LifebankUSA (USA)

LifeCell Corporation (USA)

MaxCyte, Inc. (USA)

Mesoblast Ltd. (Australia)

Millipore Corporation (USA)

NeuroGeneration, Inc. (USA)

Novartis AG (Switzerland)

NovaThera Ltd (UK)

Novo Nordisk A/B (Denmark)

Novocell, Inc. (USA)

Osiris Therapeutics, Inc. (USA)

RegenTec Ltd. (UK)

ReInnervate Ltd. (UK)

Reliance Life Sciences (India)

ReNeuron Group PLC (UK)

RhinoCyte, Inc. (USA)

Stem Cell Innovation, Inc. (USA)

Stem Cell Sciences KK (Japan)

Stem Cell Sciences PLC (UK)

Stem Cell Technology Company (Iran)

Stem Cell Therapeutics Corporation (Canada)

StemCell Technologies, Inc. (USA)

StemCells Inc. (USA)

Takara Bio, Inc. (Japan)

Vesta Therapeutics Inc. (USA)

Viacord (USA)

VistaGen Therapeutics, Inc. (USA)

Zellwerk GmbH (Germany)

4. Major Activities in Stem Cell Market

FDA Postpones Geron Corp’s Embryonic Stem Cells Clinical Trials

WARF Grants License to Invitrogen for Research with Karyotypically Normal Human

Embryonic Stem Cell

University of Edinburgh Receives Two Grants from UK Stem Cell Foundation for Collaborative

Research with Geron Corp.

New Business Enterprise Formed to Develop Treatment with Adult and

Cord Blood Stem Cells

Celgene Cellular Therapeutics succeeds in Transplanting Stem Cells obtained from

Human Placenta for correcting Hematopoietic Disturbances

KCI Acquires LifeCell for $1.7 Billion in Cash…

Osiris in Sale Agreement with NuVasive for Osteocel®…

Stem Cell Sciences Awarded US Patent for Stem Cell Media…

International Stem Cell Corporation Receives Exclusive Rights for Supplying

Artificially Developed Human Skin Models

Neuralstem Receives European Patent for Crucial Stem Cells related Technology

UCSD Joins consortium of Institutions for Research on Regenerative Technologies

MicroIslet Receives Grant from National Institute of Health

Queensland gets a New Stem Cell Research Facility

Cordlife Ltd. Granted License to Establish New Cord Blood Stem Cells Bank in India

StemCells Receives Crucial US Patent related to Human Neural Stem Cells

Asia-Cryo Cell Renamed as LifeCell International

Pentagon to Partially Finance a New Research on Regeneration of Limbs

CordLife Launches Largest Southeast Asian Cord Blood Bank in Singapore…

MediHealth and NovaThera in Manufacturing and Marketing Agreement for NovaPod™…

VistaGen Therapeutics in Stem Cell R&D Alliance with University Health Network of

Toronto and the McEwen Centre for Regenerative Medicine…

Stem Cell Therapy International Plans Merger with Histostem

Cellartis and Pfizer in Research Collaboration for Development of Screening System to

Detect Human Toxicity…

US Patent to Geron for Production of Pancreatic Islets from

Human Embryonic Stem Cells…

Angioblast and Abbott in Heart Therapy Collaboration…

Angel Biotechnology Enters into New GMP Manufacturing Contract…

BrainStorm and Rutgers University to Develop Spinal Cord Injury Therapy in Collaboration

StemCells, Inc. and Casey Eye Institute in Research Collaboration…

Osiris Obtains $224.7 Million Department of Defense Contract for Prochymal™…

Stem Cell Sciences in Diabetes R&D Agreement with a Major Pharmaceutical Company…

StemCell Technologies, Inc., is now a Subsidiary of NeoStem, Inc

Millipore Enters into Partnership Agreement with Abeome for Supplying Monoclonal

Antibodies for Application in Stem Cell Research

PerkinElmer, Inc. Acquires ViaCell, Inc

ECI starts Production of Clinical-Grade Stem Cell Lines

Stem Cell Sciences, Plc Regains Global Rights to Neural Stem Cell Technology

Innovative Muscle Stem Cells Discovery Acquired by Stem Cell Sciences

Celera Completes Acquisition of Atria Genetics, Inc.

Artificial Life Enters into Collaboration with BeFutur Biotechnologies

Cytori Receives Approval for Celution™ System in Japan

Advanced Cell Technology Acquires Complete Stake in Mytogen

Thermo Fisher Scientific and Cellular Engineering Technologies

form Partnership Alliance

Osiris Associates with Genzyme for Developing Medical Countermeasures for Nuclear and

Radiological Intimidation

ReNeuron Acquires Business Assets of AmCyte Inc,.

Summit is the New Name for Vastox

ReproCELL Enters into Collaboration Agreement with ReproCELL for Enhancing

the Studies Based on Stem Cell

Stemcell Pharma Merges with Zandcell

Pioneer Surgical Technology Enters the Orthobiologics Market with its

Acquisition of Encelle, Inc.

Wisconsin Alumni Research Foundation Grants Worldwide Licenses to

Stem Cell Technologies and BD Biosciences

Cytori Sells HYDROSORB™ Surgical Implant Product Line to Kensey Nash

Stanford Researchers Announce New Discovery in the Field of

Human Stem Cells Transplantation

BioEden Expands Operations into Europe

Vitrolife Enters into Collaboration with Cellartis

Stem Cell Sciences Acquires Rights to Novel Discovery Technology for the

Production of Human Stem Cells

Geron Acquires Additional Stake in TA Therapeutics Joint Venture

Roslin Researchers Derive Stem Cells from New Source

ReNeuron Scientists Announce Generation of Pancreatic Cell Lines

Discovery in ZebraFish may aid Human Blood Cell Transplants

Stem Cell Innovations Enters into Collaboration with High Q Foundation

Stem Cells to Replace Damaged Heart Muscle

Advanced Cell Technology Announces the Development of hESC Line without

Damaging an Embryo

Canadian Researchers Redefine Stem Cells

ThermoGenesis Enters into Agreement with University of California (UC)

Stem Cell Program (SCP)

Stem Cell Innovations and TNO Enter into Collaboration

Pluristem Purchases Patents for the 3-D Expansion of Human Cells

Epistem and AstraZeneca Undertake Joint Studies on the Development of Novel

Cancer Drugs Employing the Biomarker Technology

BioE Enters into Collaboration with Phillips Plastics for Developing and Marketing

Stem Cell Therapeutics

NovaThera Enters into Alliance with Gamida Cell Developing Cell-based Therapeutics

Invitrogen Joins Hands with Cytori for Providing Research Products Based

on Adipose Stem Cell

ReNeuron Group goes for Alliance to Upgrade its Stem Cell Expansion Technology

H. Lundbeck Enters into Agreement with Stem Cell Innovations, Inc

Consensus Business Group Acquires Stake in Hadasit Bio-Holdings

StemLifeLine Introduces Premier Service for the Development of Personal Stem Cell Lines

Israeli Government Grants US$ 830,000 to Pluristem

Lexicon Genetics now Called Lexicon Pharmaceuticals Continues with its

Drug Development Pipeline

ThromboGenics Enters into License Agreement with Millipore

Amatokin launched in the US

Calbatech Establishes a Subsidiary Company for Offering Stem Cell Service in the UK

Stemcell Signs Agreement with Aldagen for Supplying Aldecount

Pluristem Enters into a Licensing Agreement with Stem Cell

Celogos Grants License for its Autogenous Myoblast Transplantation for Urinary

Incontinence Therapy to Stem Cell Sciences KK

Merck & Co obtains Neural Stem Cells and Technology for Research

DSM Extends Partnership Agreement with Crucell

Merck Receives Licenses of Neural Stem Cell Technology from SCS

SCS Enters into MTA Pact with Henderson

Angel Biotechnology Enters into Alliance with CellGenea

MC Employs HEScGRO™ Medium Human Embryonic Stem Cell Study

Chromos Signs Contract with Genitope

ACT Acquires Technology Assets of Infigen

BCT Undertakes Research on Stem Cell Safety in Primates for Curing Parkinson’s

TIGENIX Joins Hands with FIDIA for Developing New Biological Implants…

ES Cell Signs License Agreement with ITI

Stem Cell Innovations Signs Collaboration Agreement with ALSA

CyGenics Signs Partnership Agreement with ZBC

Mediatech Enters into Alliance with GlobalStem

Gamida Cell Enters into SPA Agreement with FDA

Vistagen Reinforces its Partnership with Sanwa

StemCells Carries out Phase I Studies of HuCNS-SC™

Aldagen Joins Hands with IMT

Chromos Signs Contract with Y’s Therapeutics for Developing Cell Line

Geron Signs Collaboration Agreement with The University of Edinburgh

ACT Develops New Technology for hES Cells Culture

Stem Cell Sciences Partners with Neurosolutions

Cambrex Joins Hands with Cytori to Market Stem Cell Products

ViaCell Enters into Alliance with Centocor

Pierre Fabre Employs SURE Technology for Developing Mammalian Cell Lines

PrimeGen Emphasizes on PrimeCell™ Development

CellResearch Develops New Range of Cord Lining Stem Cells

Geron Joins Hands with University of Oxford

Cryo-Cell Commences Web-Interface for Placental Stem cells

Aldagen Receives US Patent Rights for Key Stem Cell

Geron Signs Pact with MaxCyte

Vitro Joins Hands with PhosphoSolutions for Stem Cell Proteomics Study

Xcyte Merges with Cyclacel to Form Biopharmaceutical MNC

StemCo Adopts New Corporate Identity (Aldagen)

Cytori Therapeutics Signs Collaboration Agreement with Olympus

Cryo-Cell Signs Global Marketing Agreement with Plureon

Artificial Life Associates with BeFutur

LCT Enters into Joint Venture Agreement with MultiCell

SAFC Biosciences Signs Partnership Agreement with Chromos

Axordia Enters into Collaboration with Chemicon for Developing Human Embryonic

Stem Cell Antibody Markers

A.C.T. Renames as Advanced Cell Technology

U.S. BioDefense Enteres into Collaboration with University of Texas

ViaCell Enters into Alliance with Genzyme on Diabetes Program

Geron Enters into Alliance with Cambrex to Develop and Market Human Cell Lines

5. Major Product Innovations / Launches

StemCor Systems to Receive NIH SBIR Grant for Bone Marrow Harvesting Product

Human Parthenogenetic Stem Cells Developed by International Stem Cell Corporation being

Examined for Potential in Treating Liver Diseases

Invitrogen Introduces Animal Origin Free Substrate for Stem Cells

FDA allows Osiris Therapeutics to Initiate Expanded Access Program with Prochymal

Stemcell Acquires Geron Intellectual Property to Develop Media and Matrices

for Stem Cell Growth

FDA Allows University of Miami and BioCardia for Testing of Two

Adult Stem Cell based Products

Researchers at Standford Succeed in Creating Cancer Stem Cells from Normal Skin Cells

ImmuneRegen® Joins with BioCure for Developing New Wound-Healing Therapy

Lifebank Corp., Introduces Sterile Field Cord Blood Collection unit in the Country

TaiGen Initiates US FDA Phase I trials of TG-0054, a Stem Cell Mobilizer

Aldagen Announces First Patient Treated

Enrollment Completed for Investigator-Initiated Stem & Regenerative Cell

Breast Augmentation Study in Japan

Allogeneic Cells of Mesoblast Provide Sustained effect in Knee

Osteoarthritis Preclinical Trials

VistaGen to Isolate Earliest Embryonic Stem Cell-Derived Human Cardiac Cell

StemCell Technologies Launches New Procedure to Identify and Quantify Neural Stem and

Progenitor Cells in Vitro

Efficient Generation of Functional Hepatocytes (Liver cells) from Human Embryonic

Stem Cells by Advanced Cell Technology

Stem Cells of Mesoblast Provide Rapid Fracture Healing in Clinical Trials

Stem Cell Tested Initiative Millicell® 1 m Plates Second Qualified Product of Millipore

Novocell Successfully Utilizes Stem Cells for Insulin Generation in Mice

Autologous Stem Cell Therapy to First Patient by Aastrom

Cytori Treats First Patients in its Stem & Regenerative Cell Heart Attack Study

Osiris Therapeutics Reclaim Worldwide Rights to Prochymal

Millipore to Offer Stem Cell Tested Products

MediHealth and NovaThera Develop the Innovative NovaPod™ Designed for Stem Cell Based

Applications

Invitrogen Launches STEMPRO(R) EZChek(TM) Multiplex PCR Kit

Invitrogen Launches Innovative Media Designed for hESCs

BD Biosciences Associates with Stemcell Technologies to Introduce Advanced

Culture Environment for Application in hESC Research

Invitrogen Introduces New Engineered Stem Cell Line

Millipore Launches MEL Cell Lines

Cells4Life Launches Guava PCA System

MIT Announces Release of Firefly 3000 Protein Assay Platform

GE Healthcare Releases AXP AutoXpress Platform

ReNeuron and Millipore Introduce ReNcellTM Neural Stem Cell Lines

6. Regional Market Analysis

A. North America

Market Analysis

Exhibit 62: Stem Cells (2005-2012) - North American

Market Analysis (Current & Future) in US$ Million

(Graphical Representation included)

Exhibit 63: List of Major Companies in North America

Analysis by Geographic Region

Exhibit 64: Stem Cells (2005-2012) - North American Market Analysis (Current & Future)

by Geographic Region for United States, Canada and Mexico

in US$ Million (Graphical Representation included)

Exhibit 65: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

North American Market Value by Geographic Region for

United States, Canada and Mexico

Analysis by Stem Cell Type

Exhibit 66: Stem Cells (2005-2012) - North American Market Analysis

(Current & Future) by Category for Adult Stem Cells, Cord Blood Stem Cells and

Embryonic Stem Cells in US$ Million (Graphical Representation included)

Exhibit 67: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

North American Market Value by Category for Adult Stem Cells,

Cord Blood Stem Cells and Embryonic Stem Cells

Analysis by Technology

Exhibit 68: Stem Cells (2005-2012) - North American Market Analysis (Current & Future)

by Stem Cell Technology for Stem Cell (SC) Transplantation, Cell Based (CB)

Genomics, Xenotransplantation, Cord Blood Banking and Other

in US$ Million (Graphical Representation included)

Exhibit 69: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of North American

Market Value by Stem Cell Technology for Stem Cell (SC) Transplantation,

Cell Based (CB) Genomics, Xenotransplantation, Cord Blood Banking and Other

Analysis by Therapeutic Area

Exhibit 70: Stem Cells (2005-2012) - North American Market Analysis

(Current & Future) by Therapeutic Area for Neurology, Bone and Cartilage,

Cancer, Hematology, Cardiology, Dermatology, Diabetes and

*Other in US$ Million (Graphical Representation included)

Exhibit 71: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of North American

Market Value by Therapeutic Area for Neurology, Bone and Cartilage, Cancer,

Hematology, Cardiology, Dermatology, Diabetes and Other

North American Stem Cell Market By Country

A1. United States

The US Market Scenario

The President's Criteria

The Role of the NIH

The US Backs Stem Cell Research

The US Market Analysis

Exhibit 72: Stem Cells (2005-2012) - United States Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 73: List of Cord Blood/Stem Cell Banks in the United States

A2. Canada

Canadian Market Scenario

Guidelines for Stem Cell Research

Canadian Cord Blood Banking Sector

Canadian Market Analysis

Exhibit 74: Stem Cells (2005-2012) - Canadian Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 75: List of Cord Blood/Stem Cell Banks in Canada

A3. Mexico

Mexican Market Scenario

Mexican Market Analysis

Exhibit 76: Stem Cells (2005-2012) - Mexican Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 77: List of Cord Blood/Stem Cell Banks in Mexico

B. Europe

Funding for Stem Cell Research in Europe

Cord Blood Banking in Europe

Market Analysis

Exhibit 78: Stem Cells (2005-2012) - European Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 79: List of Major Companies in Europe

Analysis by Geographic Region

Exhibit 80: Stem Cells (2005-2012) - European Market Analysis (Current & Future)

by Geographic Region for United Kingdom, Germany, France, Spain, Denmark

and Rest of Europe in US$ Million (Graphical Representation included)

Exhibit 81: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of European

Market Value by Geographic Region for United Kingdom, Germany, France,

Spain, Denmark and Rest of Europe (Graphical Representation included)

Market Analysis for Select Rest of Europe Countries

Exhibit 82: Stem Cells (2005-2012) - Rest of Europe Market Analysis

(Current & Future) by Country for Russia, Sweden, Switzerland, Poland,

Austria and Greece in US$ Million (Graphical Representation included)

Exhibit 83: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of Rest of

Europe Market Value by Geographic Region for Russia, Sweden,

Switzerland, Poland, Austria and Greece

Analysis by Stem Cell Type

Exhibit 84: Stem Cells (2005-2012) - European Market Analysis (Current & Future)

by Category for Adult Stem Cells, Cord Blood Stem Cells and

Embryonic Stem Cells in US$ Million (Graphical Representation included)

Exhibit 85: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of European

Market Value by Category for Adult Stem Cells, Cord Blood Stem Cells and

Embryonic Stem Cells

Analysis by Technology

Exhibit 86: Stem Cells (2005-2012) - European Market Analysis (Current & Future)

by Stem Cell Technology for Stem Cell (SC) Transplantation, Cell Based (CB)

Genomics, Xenotransplantation, Cord Blood Banking and

Other in US$ Million (Graphical Representation included)

Exhibit 87: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of European Market

Value by Stem Cell Technology for Stem Cell (SC) Transplantation, Cell Based (CB)

Genomics, Xenotransplantation, Cord Blood Banking and Other

Analysis by Therapeutic Area

Exhibit 88: Stem Cells (2005-2012) - European Market Analysis (Current & Future)

by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology,

Cardiology, Dermatology, Diabetes and Other

in US$ Million (Graphical Representation included)

Exhibit 89: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

European Market Value by Therapeutic Area for Neurology,

Bone and Cartilage, Cancer, Hematology, Cardiology, Dermatology,

Diabetes and Other

European Stem Cell Market By Country

B1. The United Kingdom

The UK Market Scenario

The UK Cord Blood Banking Sector

The UK Market Analysis

Exhibit 90: Stem Cells (2005-2012) - United Kingdom Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 91: List of Cord Blood/Stem Cell Banks in the United Kingdom

B2. Germany

German Market Scenario

German Market Analysis

Exhibit 92: Stem Cells (2005-2012) - German Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 93: List of Cord Blood / Stem Cell Banks in Germany

B3. France

French Market Scenario

Cord Blood Banking in France

French Market Analysis

Exhibit 94: Stem Cells (2005-2012) - French Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 95: List of Cord Blood /Stem Cell Banks in France

B4. Spain

Spanish Market Scenario

Spanish Market Analysis

Exhibit 96: Stem Cells (2005-2012) - Spanish Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 97: List of Cord Blood / Stem Cell Banks in Spain

B5. Denmark

Danish Market Scenario

Danish Market Analysis

Exhibit 98: Stem Cells (2005-2012) - Danish Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 99: List of Major Cord Blood/Stem Cell Banks in Denmark

B6. Russia

Russian Market Analysis

Exhibit 100: Stem Cells (2005-2012) - Russian Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 101: List of Cord Blood /Stem Cell Banks in Russia

B7. Sweden

Swedish Market Scenario

Swedish Market Analysis

Exhibit 102: Stem Cells (2005-2012) - Swedish Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 103: Cord Blood /Stem Cell Bank in Sweden

B8. Switzerland

Swiss Market Scenario

Swiss Market Analysis

Exhibit 104: Stem Cells (2005-2012) - Swiss Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 105: List of Cord Blood / Stem Cell Banks in Switzerland

B9. Poland

Polish Market Scenario

Polish Market Analysis

Exhibit 106: Stem Cells (2005-2012) - Polish Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 107: List of Cord Blood/Stem Cell Banks in Poland

B10. Austria

Austrian Market Scenario

Austrian Market Analysis

Exhibit 108: Stem Cells (2005-2012) - Austrian Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 109: List of Cord Blood/Stem Cell Banks in Austria

B11. Greece

Greek Market Scenario

Greek Market Analysis

Exhibit 110: Stem Cells (2005-2012) - Greek Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 111: List of Cord Blood /Stem Cell Banks in Greece

Exhibit 112: List of Cord Blood /Stem Cell Banks in Rest of Europe

C. Asia-Pacific

Market Analysis

Exhibit 113: Stem Cells (2005-2012) - Asia-Pacific Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Analysis by Geographic Region

Exhibit 114: Stem Cells (2005-2012) - Asia-Pacific Market Analysis (Current & Future)

by Geographic Region for India, China, Japan, Australia and Rest of Asia-Pacific

in US$ Million (Graphical Representation included)

Exhibit 115: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific

Market Value by Geographic Region for India, China, Japan, Australia and

Rest of Asia-Pacific

Exhibit 116: List of Major Companies in Asia-Pacific

Market Analysis for Select Rest of Asia-Pacific Countries

Exhibit 117: Stem Cells (2005-2012) - Rest of Asia-Pacific Market Analysis

(Current & Future) by Country for South Korea, Hong Kong, Singapore,

New Zealand and Taiwan in US$ Million (Graphical Representation included)

Exhibit 118: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of Rest of

Asia-Pacific Market Value by Geographic Region for South Korea, Hong Kong,

Singapore, New Zealand and Taiwan

Analysis by Stem Cell Type

Exhibit 119: Stem Cells (2005-2012) - Asia-Pacific Market Analysis (Current & Future)

by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic

Stem Cells in US$ Million (Graphical Representation included)

Exhibit 120: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific

Market Value by Category for Adult Stem Cells, Cord Blood Stem Cells and

Embryonic Stem Cells

Analysis by Technology

Exhibit 121: Stem Cells (2005-2012) - Asia-Pacific Market Analysis (Current & Future)

by Stem Cell Technology for Stem Cell (SC) Transplantation, Cell Based (CB)

Genomics, Xenotransplantation, Cord Blood Banking and Other

in US$ Million (Graphical Representation included)

Exhibit 122: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Asia-Pacific Market Value by Stem Cell Technology for Stem Cell (SC) Transplantation,

Cell Based (CB) Genomics, Xenotransplantation,

Cord Blood Banking and Other

Analysis by Therapeutic Area

Exhibit 123: Stem Cells (2005-2012) - Asia-Pacific Market Analysis (Current & Future)

by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology,

Cardiology, Dermatology, Diabetes and *Other in US$ Million

(Graphical Representation included)

Exhibit 124: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Asia-Pacific Market Value by Therapeutic Area for Neurology,

Bone and Cartilage, Cancer, Hematology, Cardiology, Dermatology,

Diabetes and Other

Asia-Pacific Stem Cell Market by Country

C1. India

Indian Market Scenario

The Indian Cord Blood Banking Sector

Indian Market Analysis

Exhibit 125: Stem Cells (2005-2012) - Indian Market Analysis

(Current & Future) in US$ Million

(Graphical Representation included)

Exhibit 126: List of Cord Blood/ Stem Cell Banks in India

C2. China

Chinese Market Scenario

Chinese Market Analysis

Exhibit 127: Stem Cells (2005-2012) - Chinese Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 128: List of Cord Blood/Stem Cell Banks in China

C3. Japan

Japanese Market Scenario

Japanese Market Analysis

Exhibit 129: Stem Cells (2005-2012) - Japanese Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 130: List of Cord Blood/Stem Cell Banks in Japan

C4. Australia

Australian Market Scenario

Australian Market Analysis

Exhibit 131: Stem Cells (2005-2012) - Australian Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 132: List of Cord Blood/Stem Cell Banks in Australia

C5. South Korea

South Korean Market Scenario

The South Korean Cord Blood Banking Sector

South Korean Market Analysis

Exhibit 133: Stem Cells (2005-2012) - South Korean Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 134: List of Cord Blood/Stem Cell Banks in South Korea

C6. Hong Kong

Hong Kong Market Analysis

Exhibit 135: Stem Cells (2005-2012) - Hong Kong Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 136: List of Cord Blood/Stem Cell Banks in Hong Kong

C7. Singapore

Singaporean Market Scenario

Singaporean Market Analysis

Exhibit 137: Stem Cells (2005-2012) - Singaporean Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 138: List of Cord Blood/Stem Cell Banks in Singapore

C8. New Zealand

New Zealand Market Scenario

New Zealand Market Analysis

Exhibit 139: Stem Cells (2005-2012) - New Zealand Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 140: Cord Blood /Stem Cell Bank in New Zealand

C9. Taiwan

Taiwanese Market Scenario

Taiwanese Market Analysis

Exhibit 141: Stem Cells (2005-2012) - Taiwanese Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 142: List of Cord Blood/Stem Cell Banks in Taiwan

Exhibit 143: List of Cord Blood/Stem Cell Banks in Rest of Asia-Pacific

D. Rest of World

Market Analysis

Exhibit 144: Stem Cells (2005-2012) - Rest of World Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Analysis by Geographic Region

Exhibit 145: Stem Cells (2005-2012) - Rest of World Market Analysis (Current &

Future) by Geographic Region for Latin America, Middle East and Africa

in US$ Million (Graphical Representation included)

Exhibit 146: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of Rest of World

Market Value by Geographic Region for Latin America, Middle East and Africa

Exhibit 147: List of Major Companies in Rest of World

Market Analysis for Select Latin American Countries

Exhibit 148: Stem Cells (2005-2012) - Latin American Market Analysis

(Current & Future) by Geographic for Brazil, Colombia, Argentina and

Rest of Latin America in US$ Million (Graphical Representation included)

Exhibit 149: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Latin American Market Value by Geographic Region for Brazil, Colombia,

Argentina and Rest of Latin America

Market Analysis for Israel and Rest of Middle East

Exhibit 150: Stem Cells (2005-2012) - Middle East Market Analysis (Current &

Future) by Geographic Region for Israel and Rest of Middle East

in US$ Million (Graphical Representation included)

Exhibit 151: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown

of Middle East Market Value by Geographic Region for

Israel and Rest of Middle East

Analysis by Stem Cell Type

Exhibit 152: Stem Cells (2005-2012) - Rest of World Market Analysis

(Current & Future) by Category for Adult Stem Cells, Cord Blood Stem Cells and

Embryonic Stem Cells in US$ Million

(Graphical Representation included)

Exhibit 153: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Rest of World Market Value by Category for Adult Stem Cells,

Cord Blood Stem Cells and Embryonic Stem Cells

Analysis by Technology

Exhibit 154: Stem Cells (2005-2012) - Rest of World Market Analysis (Current &

Future) by Stem Cell Technology for Stem Cell (SC) Transplantation, Cell Based (CB)

Genomics, Xenotransplantation, Cord Blood Banking and

Other in US$ Million (Graphical Representation included)

Exhibit 155: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Rest of World Market Value by Stem Cell Technology for Stem Cell (SC)

Transplantation, Cell Based (CB) Genomics, Xenotransplantation,

Cord Blood Banking and Other

Analysis by Therapeutic Area

Exhibit 156: Stem Cells (2005-2012) - Rest of World Market Analysis (Current & Future)

by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology,

Cardiology, Dermatology, Diabetes and *Other in US$ Million

(Graphical Representation included)

Exhibit 157: Stem Cells (2006, 2009 and 2012) - Percentage Breakdown of

Rest of World Market Value by Therapeutic Area for Neurology,

Bone and Cartilage, Cancer, Hematology, Cardiology, Dermatology,

Diabetes and Other

Rest of World Stem Cell Market by Country

D1. Brazil

Brazilian Market Scenario

Brazilian Market Analysis

Exhibit 158: Stem Cells (2005-2012) - Brazilian Market Analysis (Current &

Future) in US$ Million (Graphical Representation included)

Exhibit 159: List of Cord Blood/ Stem Cell Banks in Brazil

D2. Colombia

Colombian Market Scenario

Colombian Market Analysis

Exhibit 160: Stem Cells (2005-2012) - Colombian Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 161: List of Cord Blood/Stem Cell Bank in Colombia

D3. Argentina

Argentinean Market Scenario

Argentinean Market Analysis

Exhibit 162: Stem Cells (2005-2012) - Argentinean Market Analysis (Current &

Future) in US$ Million (Graphical Representation included)

Exhibit 163: List of Cord Blood/Stem Cell Banks in Argentina

D4. Rest of Latin America

Rest of Latin America Market Analysis

Exhibit 164: Stem Cells (2005-2012) - Rest of Latin America Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

Exhibit 165: List of Cord Blood/Stem Cell Banks in Rest of Latin America

D5. Israel

Israeli Market Scenario

Israeli Market Analysis

Exhibit 166: Stem Cells (2005-2012) - Israeli Market Analysis (Current & Future)

in US$ Million (Graphical Representation included)

Exhibit 167: List of Cord Blood/Stem Cell Banks in Israel

D6. Rest of Middle East

Rest of Middle East Market Analysis

Exhibit 168: Stem Cells (2005-2012) - Rest of Middle East Market Analysis

(Current & Future) in US$ Million (Graphical Representation included)

D7. South Africa

South African East Market Scenario

South African East Market Analysis

Exhibit 169: Stem Cells (2005-2012) - South African Market Analysis (Current &

Future) in US$ Million (Graphical Representation included)

Exhibit 170: List of Cord Blood/Stem Cell Banks in South Africa

7. Stem Cell Research - The Industry Outlook

V. CORPORATE DIRECTORY

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.